{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:31:51Z","timestamp":1793323911960,"version":"4.5.0"},"reference-count":65,"publisher":"Open Medical Publishing","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec id=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a rising global burden of cancer cases reported annually, an increase to 35 million cases by 2050 is anticipated. Additionally, an increase in cancer survivorship due to modern oncology advancements exists. There is an increasing need for total hip arthroplasty (THA) in this cohort due to degenerative disease, metastatic disease or oncologic treatment induced bone disease. Advances in cancer treatment have led to an increasing population of cancer survivors who require orthopaedic arthroplasty procedures. The associated surgical risks are amplified in this group, including increased blood loss, decreased systemic reserves and overall frailty. Studies evaluating perioperative outcomes consistently demonstrate that patients with cancer experience increased morbidity and mortality after arthroplasty surgical procedures, compared to the general population. This underscores the need for a comprehensive understanding, risk stratification and multidisciplinary perioperative management to minimize potential surgical-associated risks. However, there are good reported outcomes with THA in cancer patients which are comparable to their controls. This review looks at the critical issues faced by reconstructive orthopaedic surgeons when treating patients with a history of cancer or active malignancy, particularly those undergoing THA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"aims-of-the-review\">\n                    <jats:title>Aims of the Review<\/jats:title>\n                    <jats:p>This narrative review aims to explore the bidirectional relationship between cancer and THA, outcomes and management strategies. It will describe the pertinent issues reconstructive surgeons face when treating patients with cancer. The goal is to highlight the clinical intersections, challenges, and necessary management strategies specific to this population. This is especially relevant in view of the rising number of cancer patients being reported globally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"key-findings\">\n                    <jats:title>Key Findings<\/jats:title>\n                    <jats:p>Key findings of the review include the elevated risks associated with cancer patients undergoing THA. Complications such as deep vein thrombosis (DVT) in patients with a history of malignancy, and early postoperative mortality in patients with active malignancy are reported. Furthermore, patients with disseminated cancer undergoing elective THA have significantly elevated risks for death and various postoperative complications. It is imperative that adequate preoperative work up, intraoperative planning and post operative management strategies are employed in such cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"conclusion\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The global cancer burden is increasing, along with improved survivorship, this has created a growing subpopulation of patients requiring THA. Surgery in cancer patients presents unique challenges and increased perioperative risks. This underscores the need for comprehensive risk stratification and a multidisciplinary management approach to minimize potential risks. THA offers vital functional and palliative benefits to cancer patients. Therefore, ongoing research and advances in this area are imperative for specialised and effective care for these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.52965\/001c.162147","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T22:57:21Z","timestamp":1781996241000},"source":"Crossref","is-referenced-by-count":0,"title":["Cancer and total hip arthroplasty: a narrative review of clinical intersections, challenges and outcomes"],"prefix":"10.52965","volume":"18","author":[{"given":"Winifred","family":"Mukiibi","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Arthroplasty Unit, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa"},{"name":"Division of Orthopaedic Surgery, School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehlin","family":"Moodley","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkhodiseni","family":"Sikhauli","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Arthroplasty Unit, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa"},{"name":"Division of Orthopaedic Surgery, School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurek R. T.","family":"Pietrzak","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Arthroplasty Unit, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa"},{"name":"Division of Orthopaedic Surgery, School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"30777","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.52965\/001c.94568","article-title":"Hip Arthroplasty Outcomes in Patients with Metastatic Bone Disease","volume":"16","author":"S.C. Tepper","year":"2024","journal-title":"Orthopedic Reviews"},{"issue":"20","key":"ref2","doi-asserted-by":"publisher","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"R. E. Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00270-023-03425-x","article-title":"Comparison of Percutaneous Interventional Ablation- Osteoplasty-Reinforcement-Internal Fixation (AORIF), Long Intramedullary Nailing, and Hemiarthroplasty for the Treatment of Focal Metastatic Osteolytic Lesions in the Femoral Head and Neck","volume":"46","author":"W. Jiang","year":"2023","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.21037\/aoj-20-97","article-title":"Narrative review of the epidemiology, economic burden, and societal impact of metastatic bone disease","volume":"7","author":"M. R. DiCaprio","year":"2022","journal-title":"Ann Jt"},{"issue":"6","key":"ref5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"P. Haentjens","year":"2010","journal-title":"Ann Intern Med"},{"issue":"3","key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10187","article-title":"Cancer- and Chemotherapy-Induced Musculoskeletal Degradation","volume":"3","author":"K. Sturgeon","year":"2019","journal-title":"JBMR"},{"issue":"4","key":"ref7","doi-asserted-by":"publisher","first-page":"e83082","DOI":"10.7759\/cureus.83082","article-title":"Understanding and Managing Fracture Risk in Patients With Cancer: A Literature Review","volume":"17","author":"E. Kourtis","year":"2025","journal-title":"Cureus"},{"issue":"2","key":"ref8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.11138\/ccmbm\/2015.12.2.116","article-title":"Prevention and treatment of bone fragility in cancer patient","volume":"12","author":"S. Ottanelli","year":"2015","journal-title":"Clinical Cases in Mineral and Bone Metabolism"},{"issue":"2","key":"ref9","first-page":"48","article-title":"Alteration of bone quality and prevalence of fragility fractures in patients with breast cancer treated with aromatase inhibitors. A case-control study","volume":"16","author":"M., et al. Tejada-Romero","year":"2024","journal-title":"Rev Osteoporos Metab Miner"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.210061","article-title":"Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate CancerReceiving Androgen-Deprivation Therapy","author":"Enrique, et al. Casado","year":"2022","journal-title":"The World Journal of Men's Health"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"R. L. Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00198-018-4722-3","article-title":"Patients with prostate cancer and androgen deprivation therapy have increased risk of fractures\u2014a study from the fractures and fall injuries in the elderly cohort (FRAILCO)","volume":"30","author":"M. Wallander","year":"2019","journal-title":"Osteoporosis International"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s00198-024-07180-8","article-title":"The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy","volume":"35","author":"M., et al. Oostwaard","year":"2024","journal-title":"Osteoporosis International"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41391-020-00296-y","article-title":"Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer","volume":"24","author":"A., et al. Hussain","year":"2021","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-7568(23)00285-4","article-title":"Risk of fractures in half a million survivors of 20 cancers: a population-based matched cohort study using linked English electronic health records","author":"E., et al. Buzasi","year":"2024"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41416-023-02353-4","article-title":"Fracture risk among cancer patients","author":"I. Y., et al. Gong","year":"2023","journal-title":"Br J Cancer"},{"issue":"6","key":"ref17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"K. N. Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"ref18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2217\/fon.12.76","article-title":"The multifaceted actions of PTHrP in skeletal metastasis","volume":"8","author":"F. N. Soki","year":"2012","journal-title":"Future Oncol"},{"issue":"14 Suppl 5","key":"ref19","first-page":"9","article-title":"Bone biology and the role of the RANK ligand pathway","volume":"23","author":"R.K. Murthy","year":"2009","journal-title":"Oncol Williston Park N"},{"issue":"7","key":"ref20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1210\/js.2018-00052","article-title":"Cancer treatment\u2013induced bone loss in women with breast cancer and men with prostate cancer","volume":"2","author":"P. Taxel","year":"2018","journal-title":"J Endocr Soc"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1007\/s00198-011-1870-0","article-title":"Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper","volume":"23","author":"R., et al. Rizzoli","year":"2012","journal-title":"Osteoporos Int"},{"issue":"3","key":"ref22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F. Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"ref23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/MCO.0b013e328339fdd2","article-title":"Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies","volume":"13","author":"K. Burckart","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"ref24","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"V. E. Baracos","year":"2018","journal-title":"Nat Rev Dis Primer"},{"issue":"1","key":"ref25","doi-asserted-by":"publisher","first-page":"9890633","DOI":"10.1155\/2022\/9890633","article-title":"Systematic review on multilevel analysis of radiation effects on bone microarchitecture","volume":"2022","author":"A. A. A. Bakar","year":"2022","journal-title":"Biomed Res Int"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s11914-015-0266-z","article-title":"Chemotherapy- and Irradiation-Induced Bone Loss in Adults with Solid Tumors","volume":"13","author":"M. Wissing","year":"2015","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"ref27","doi-asserted-by":"publisher","first-page":"100571","DOI":"10.1016\/j.adro.2020.09.011","article-title":"Long-term risk of hip complications after radiation therapy for prostate cancer: a dose-response study","volume":"6","author":"E. Rasmusson","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1016\/j.arth.2020.06.080","article-title":"Mortality and Complications in Patients with Metastatic Disease after Primary Total Hip and Total Knee Arthroplasty","author":"M. Sloan","year":"2020","journal-title":"The Journal of Arthroplasty"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jjoisr.2024.11.002","article-title":"Hip fracture and cancer: descriptive epidemiological study demonstrating a paradigm shift in common orthopedic trauma","volume":"3","author":"J., et al. Teramoto","year":"2025","journal-title":"Journal of Joint Surgery and Research"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1016\/j.arth.2023.05.066","article-title":"Total Hip Arthroplasty Outcomes in Patients Who Have a History of Prior Radiation","volume":"38","author":"M. Lavu","year":"2023","journal-title":"The Journal of Arthroplasty"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1302\/2633-1462.46.BJO-2023-0042.R1","article-title":"Prevalence of primary malignant tumours, rates of pathological fracture, and mortality in the setting of metastatic bone disease","volume":"4-6","author":"A. B., et al. Christ","year":"2023","journal-title":"Bone Jt Open"},{"issue":"3","key":"ref32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.15438\/rr.4.3.74","article-title":"Peri-prosthetic infection in the orthopedic tumor patient","volume":"4","author":"Md Allison","year":"2014","journal-title":"Reconstr Rev"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.arth.2014.12.017","article-title":"Total joint arthroplasty in cancer patients","author":"J. Karam","year":"2015","journal-title":"The Journal of Arthroplasty"},{"issue":"12","key":"ref34","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1007\/s00402-024-05307-4","article-title":"Initiating chemotherapy in joint arthroplasty patients increases the risk of periprosthetic joint infections","volume":"144","author":"A. H. Hoveidaei","year":"2024","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"ref35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/ALN.0b013e31825afd36","article-title":"Utilization of critical care services among patients undergoing total hip and knee arthroplasty: epidemiology and risk factors","volume":"117","author":"S. G. Memtsoudis","year":"2012","journal-title":"Anesthesiology"},{"issue":"1","key":"ref36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1537-2995.2010.02797.x","article-title":"Risk for perioperative myocardial infarction and mortality in patients undergoing hip or knee arthroplasty: the role of anemia","volume":"51","author":"C. B. Mantilla","year":"2011","journal-title":"Transfusion (Paris)"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jor.2020.04.022","article-title":"Outcomes of press-fit uncemented versus cemented hip arthroplasty in the oncologic patient","volume":"22","author":"C. G. Larsen","year":"2020","journal-title":"J Orthop"},{"issue":"4","key":"ref38","doi-asserted-by":"publisher","first-page":"798","DOI":"10.2106\/JBJS.F.00183","article-title":"Uncemented total hip arthroplasty in patients with a history of pelvic irradiation for prostate cancer","volume":"89","author":"K. I. Kim","year":"2007","journal-title":"J Bone Jt Surg"},{"issue":"9","key":"ref39","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.arth.2012.03.036","article-title":"Uncemented arthroplasty for metastatic disease of the hip","volume":"27","author":"R. Thein","year":"2012","journal-title":"J Arthroplasty"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jbo.2018.02.006","article-title":"No consensus on implant choice for oligometastatic disease of the femoral head and neck","volume":"12","author":"T. J. Reif","year":"2018","journal-title":"J Bone Oncol"},{"issue":"5","key":"ref41","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s43465-021-00471-w","article-title":"Dual mobility in total hip arthroplasty: biomechanics, indications and complications\u2013current concepts","volume":"55","author":"N. Patil","year":"2021","journal-title":"Indian J Orthop"},{"issue":"4","key":"ref42","doi-asserted-by":"publisher","first-page":"E184","DOI":"10.5435\/JAAOS-D-23-00608","article-title":"Dual Mobility for Oncological Hip Reconstruction: Significantly Reduced Dislocation Rates at 5 years","volume":"32","author":"D. Karczewski","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"ref43","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13018-025-05910-0","article-title":"Proximal femur replacement in oncologic lesion: hemiarthroplasty vs total hip arthroplasty\u2014a multicentric retrospective study","volume":"20","author":"M. Salvini","year":"2025","journal-title":"J Orthop Surg"},{"key":"ref44","first-page":"187","article-title":"Total joint arthroplasty in patients with a history of cancer","author":"W. Matar","year":"2012","journal-title":"Am J Orthop"},{"issue":"11","key":"ref45","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1111\/ans.18335","article-title":"Limb salvage surgery reconstructive techniques following long-bone lower limb oncological resection: a systematic review and meta-analysis","volume":"93","author":"O. Hovav","year":"2023","journal-title":"ANZ J Surg"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1051\/sicotj\/2025031","article-title":"Implant survival and risk factors for failure after proximal femoral megaprosthetic reconstruction","volume":"11","author":"A. G. Roustemis","year":"2025","journal-title":"Sicot-J"},{"issue":"5","key":"ref47","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s11999-011-2149-7","article-title":"Histologic examinations of arthroplasty specimens are not cost-effective: a retrospective cohort study","volume":"470","author":"M. M. Lin","year":"2012","journal-title":"Clin Orthop"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"101079","DOI":"10.1016\/j.artd.2022.101079","article-title":"Routine pathologic examination of the femoral head in total hip arthroplasty: a survey study of the american association of hip and knee surgeons","volume":"19","author":"S. Nandi","year":"2023","journal-title":"Arthroplasty Today"},{"issue":"1","key":"ref49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5371\/hp.2022.34.1.56","article-title":"Evaluation of the cost effectiveness of routine histopathologic femoral head analysis in hip arthroplasty","volume":"34","author":"Z. Brown","year":"2022","journal-title":"Hip Pelvis"},{"issue":"1","key":"ref50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5152\/j.aott.2025.24021","article-title":"Routine histopathological examination of femoral heads and incidental metastatic bone disease in hip arthroplasty","volume":"59","author":"O. Birsel","year":"2025","journal-title":"Acta Orthop Traumatol Turc"},{"issue":"7","key":"ref51","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2106\/00004623-199907000-00004","article-title":"Analysis of routine histological evaluation of tissues removed during primary hip and knee arthroplasty","volume":"81","author":"T. Lawrence","year":"1999","journal-title":"J Bone Joint Surg Am"},{"issue":"23","key":"ref52","first-page":"e481","article-title":"Assessing the necessity of routine histopathological examination of femoral heads followingarthroplasty for fracture","volume":"26","author":"M. M. Lin","year":"2018","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"ref53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0883-5403(97)90048-6","article-title":"Collection of surgical specimens in total joint arthroplasty: is routine pathology cost-effective?","volume":"12","author":"M. L. Campbell","year":"1997","journal-title":"J Arthroplasty"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.52965\/001c.77877","article-title":"Do cemented standard-length femoral stems have enough longevity for the pathological fractures of femoral neck with metastatic lesions? A retrospective study","author":"P., et al. Tuntarattanapong","year":"2023","journal-title":"Orthop Rev"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"24362443","DOI":"10.1016\/j.arth.2017.03.002","article-title":"Hematologic Malignancies Are Associated With Adverse Perioperative Outcomes After Total Hip Arthroplasty","author":"J., et al. Newman","year":"2017","journal-title":"The Journal of Arthroplasty"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.artd.2022.07.020","article-title":"Prostate cancer history and total hip arthroplasty: a matched cohort analysis investigating venous thromboembolism and anticoagulation","volume":"17","author":"K. Johnson","year":"2022","journal-title":"Arthroplasty Today"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e2383","DOI":"10.1136\/bmj.e2383","article-title":"National Joint Registry of England and Wales. Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: linkage study","volume":"344","author":"A. J. Smith","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/17453674.2018.1431854","article-title":"Risk of cancer after primary total hip replacement: the influence of bearings, cementation and the material of the stem","volume":"89","author":"V. Leva\u0161i\u010d","year":"2018","journal-title":"Acta Orthop"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s12891-020-03605-7","article-title":"A prospective study on cancer risk after total hip replacements for 41 402 patients linked to the Cancer Registry of Norway","volume":"21","author":"E. Dybvik","year":"2020","journal-title":"BMC Musculoskelet Disord"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/cancers1601339","article-title":"Long-term cancer risk following primary and revision total hip arthroplasty in Hong Kong: a 16-year cohort study","volume":"16","author":"C. W. Y., et al. Sun","year":"2024","journal-title":"Cancers (Basel)"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41416-023-02353-4","article-title":"Oncology Patients Are High Cost Outliers in Total Joint Replacement Bundled Payment Systems","volume":"35","author":"E., et al. Woelber","year":"2020","journal-title":"The Journal of Arthroplasty"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2340\/17453674.2022.2044","article-title":"Similar risk of cancer in patients younger than 55 years with or without a total hip arthroplasty (THA)","author":"Y. Hailer","year":"2022","journal-title":"Acta Orthop"},{"issue":"S3","key":"ref63","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.21037\/atm.2017.11.18","article-title":"National use of total hip arthroplasty among patients with a history of breast, lung, prostate, colon or bladder cancer\u2014an analysis of the medicare population","volume":"5","author":"S. Rosas","year":"2017","journal-title":"Ann Transl Med"},{"issue":"2","key":"ref64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/107327481201900202","article-title":"Overview of diagnosis and management of metastatic disease to bone","volume":"19","author":"H. H. Michael","year":"2012","journal-title":"Cancer Control"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.amsu.2018.09.042","article-title":"Surgical management of metastatic lesions of proximal femur and the hip","volume":"36","author":"M. J. Khattak","year":"2018","journal-title":"Annals of Medicine and Surgery"}],"container-title":["Orthopedic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/orthopedicreviews.openmedicalpublishing.org\/article\/162147-cancer-and-total-hip-arthroplasty-a-narrative-review-of-clinical-intersections-challenges-and-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:46:06Z","timestamp":1793321166000},"score":1,"resource":{"primary":{"URL":"https:\/\/orthopedicreviews.openmedicalpublishing.org\/article\/162147-cancer-and-total-hip-arthroplasty-a-narrative-review-of-clinical-intersections-challenges-and-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":65,"URL":"https:\/\/doi.org\/10.52965\/001c.162147","relation":{},"ISSN":["2035-8164"],"issn-type":[{"value":"2035-8164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]}}}